CHRISTINA TAYLOR: Open Payments
NPI 1194443036 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 25 payments from 11 companies in 2025. Trend: 2023 $733 · 2024 $1,126 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $344 |
| Stryker Corporation | 1 | $163 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Novo Nordisk Inc | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Grifols USA, LLC | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Verona Pharma, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| CSL Behring | 1 | $19 |
Products named: AIRSUPRA, 1788, BREZTRI, NUCALA, DUPIXENT, Xembify, Wegovy, LEQVIO.
Industry payments across FL — which companies pay providers there.
